Differential regulation of AKT, MAPK and GSK3β during C2-ceramide-induced neuronal death

NeuroToxicology

Volumn 31, Issue 6, 2010, Pages 687-693

  Arboleda, Gonzalo ^a   Cárdenas, Yolanda ^a   Rodríguez, Yeldy ^a   Morales, Luis Carlos ^a   Matheus, Luisa ^b   Arboleda, Humberto ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

AKT; Apoptosis; CAD cells; Ceramide; GSK3 ; IGF 1; MAPK

Indexed keywords

CERAMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 3; PROTEIN KINASE B; SOMATOMEDIN C;

ARTICLE; CELL CULTURE; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; NERVE CELL NECROSIS; NEUROPROTECTION; PRIORITY JOURNAL;

ANIMALS; CELL DEATH; CELL SURVIVAL; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; SPHINGOSINE;

EID: 78049457564     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.08.001     Document Type: Article

References (55)

1. Arboleda G., Waters C., Gibson R.M. Metabolic activity: a novel indicator of neuronal survival in the murine dopaminergic cell line CAD. J Mol Neurosci 2005, 27:65-78.
2. 2-ceramide in CAD cells. Eur J Neurosci 2007, 25:3030-3038.
3. Basu S., Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 1998, 17:3277-3285.
4. Bourbon N.A., Yun J., Berkey D., Wang Y., Kester M. Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions. Am J Physiol Cell Physiol 2001, 280:C1403-C1411.
5. Bras J., Singleton A., Cookson M.R., Hardy J. Emerging pathways in genetic Parkinson's disease: potential role of ceramide metabolism in Lewy body disease. FEBS J 2008, 275:5767-5773.
6. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001, 11:297-305.
7. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci USA 2000, 97:10236-10241.
8. Cross D.A., Alessi D.R., Vandenheede J.R., McDowell H.E., Hundal H.S., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 1994, 303:21-26.
9. Crowder R.J., Freeman R.S. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 2000, 275:34266-34271.
10. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
11. Dhanasekaran D.N., Reddy E.P. JNK signaling in apoptosis. Oncogene 2008, 27(48):6245-6251.
12. Di Bartolomeo S., Spinedi A. Ordering ceramide-induced cell detachment and apoptosis in human neuroepithelioma. Neurosci Lett 2002, 334:149-152.
13. D'Mello S.R., Chin P.C. Treating neurodegenerative conditions through the understanding of neuronal apoptosis. Cur Drug Targets CNS Neurol Disord 2005, 4:3-23.
14. France-Lanord V., Brugg B., Michel P.P., Agid Y., Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J Neurochem 1997, 69:1612-1621.
15. Frebel K., Wiese S. Signalling molecules essential for neuronal survival and differentiation. Biochem Soc Trans 2006, 34:1287-1290.
16. Gary D.S., Mattson M.P. Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. J Neurochem 2001, 76:1485-1496.
17. Gimenez-Cassina A., Lim F., Cerrato T., Palomo G.M., az-Nido J. Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3. J Biol Chem 2009, 284:3001-3011.
18. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001, 65:391-426.
19. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996, 15:2760-2770.
20. Ham J., Eilers A., Whitfield J., Neame S.J., Shah B. c-Jun and the transcriptional control of neuronal apoptosis. Biochem Pharmacol 2000, 60:1015-1021.
21. Hannun Y.A., Obeid L.M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008, 9:139-150.
22. Harper S.J., LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001, 13:299-310.
23. Hommes D.W., Peppelenbosch M.P., van Deventer S.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003, 52:144-151.
24. Horton C.D., Qi Y., Chikaraishi D., Wang J.K. Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line. J Neurochem 2001, 76:201-209.
25. Jones D.M., Tucker B.A., Rahimtula M., Mearow K.M. The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J Neurochem 2003, 86:1116-1128.
26. Kim D.K., Cho E.S., Seong J.K., Um H.D. Adaptive concentrations of hydrogen peroxide suppress cell death by blocking the activation of SAPK/JNK pathway. J Cell Sci 2001, 114:4329-4334.
27. King T.D., Bijur G.N., Jope R.S. Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res 2001, 919:106-114.
28. Knusel B., Gao H., Okazaki T., Yoshida T., Mori N., Hefti F., et al. Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience 1997, 78:851-862.
29. Levresse V., Butterfield L., Zentrich E., Heasley L.E. Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J Neurosci Res 2000, 62:799-808.
30. Levy O.A., Malagelada C., Greene L.A. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14:478-500.
31. Lin C.F., Chen C.L., Chiang C.W., Jan M.S., Huang W.C., Lin Y.S. GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. J Cell Sci 2007, 120:2935-2943.
32. Linseman D.A., Butts B.D., Precht T.A., Phelps R.A., Le S.S., Laessig T.A., et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004, 24:9993-10002.
33. Maroney A.C., Finn J.P., Connors T.J., Durkin J.T., Angeles T., Gessner G., et al. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem 2001, 276:25302-25308.
34. Maurer U., Charvet C., Wagman A.S., Dejardin E., Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006, 21:749-760.
35. Nair V.D., Olanow C.W. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses. J Biol Chem 2008, 283:15469-15478.
36. Ness J.K., Wood T.L. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis. Mol Cell Neurosci 2002, 20:476-488.
37. Ness J.K., Mitchell N.E., Wood T.L. IGF-I and NT-3 signaling pathways in developing oligodendrocytes: differential regulation and activation of receptors and the downstream effector Akt. Dev Neurosci 2002, 24:437-445.
38. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000, 407:810-816.
39. Panigone S., Bergomas R., Fontanella E., Prinetti A., Sandhoff K., Grabowski G.A., et al. Up-regulation of prosaposin by the retinoid HPR and its effect on ceramide production and integrin receptors. FASEB J 2001, 15:1475-1477.
40. Romanelli R.J., LeBeau A.P., Fulmer C.G., Lazzarino D.A., Hochberg A., Wood T.L. Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt. J Biol Chem 2007, 282:22513-22524.
41. Sathyanarayana P., Barthwal M.K., Kundu C.N., Lane M.E., Bergmann A., Tzivion G., et al. Activation of the Drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3. Mol Cell 2002, 10:1527-1533.
42. Schubert K.M., Scheid M.P., Duronio V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J Biol Chem 2000, 275:13330-13335.
43. Shimoke K., Yamagishi S., Yamada M., Ikeuchi T., Hatanaka H. Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons. Brain Res Dev Brain Res 1999, 112:245-253.
44. Stoica B.A., Movsesyan V.A., Knoblach S.M., Faden A.I. Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol Cell Neurosci 2005, 29:355-371.
45. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996, 380:75-79.
46. Virdee K., Tolkovsky A.M. Activation of p44 and p42 MAP kinases is not essential for the survival of rat sympathetic neurons. Eur J Neurosci 1995, 7:2159-2169.
47. Virdee K., Tolkovsky A.M. Inhibition of p42 and p44 mitogen-activated protein kinase activity by PD98059 does not suppress nerve growth factor-induced survival of sympathetic neurones. J Neurochem 1996, 67:1801-1805.
48. Willaime S., Vanhoutte P., Caboche J., Lemaigre-Dubreuil Y., Mariani J., Brugg B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 2001, 13:2037-2046.
49. Willaime-Morawek S., Brami-Cherrier K., Mariani J., Caboche J., Brugg B. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 2003, 119:387-397.
50. Willaime-Morawek S., Arbez N., Mariani J., Brugg B. IGF-I protects cortical neurons against ceramide-induced apoptosis via activation of the PI-3K/Akt and ERK pathways; is this protection independent of CREB and Bcl-2?. Brain Res Mol Brain Res 2005, 142:97-106.
51. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
52. Xue L., Murray J.H., Tolkovsky A.M. The Ras/phosphatidylinositol 3-kinase and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J Biol Chem 2000, 275:8817-8824.
53. Yamagishi S., Matsumoto T., Yokomaku D., Hatanaka H., Shimoke K., Yamada M., et al. Comparison of inhibitory effects of brain-derived neurotrophic factor and insulin-like growth factor on low potassium-induced apoptosis and activation of p38 MAPK and c-Jun in cultured cerebellar granule neurons. Brain Res Mol Brain Res 2003, 119:184-191.
54. Zhou H., Summers S.A., Birnbaum M.J., Pittman R.N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 1998, 273:16568-16575.
55. Zundel W., Swiersz L.M., Giaccia A. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol Cell Biol 2000, 20:1507-1514.